Gil Rabinovici, MD - Unpacking the Latest Evidence on Biomarkers and ATTs in the Diagnosis and Management of Alzheimer's Disease: Breaking Updates From CTAD 2025
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Gil Rabinovici, MD - Unpacking the Latest Evidence on Biomarkers and ATTs in the Diagnosis and Management of Alzheimer's Disease: Breaking Updates From CTAD 2025
-
ナレーター：
-
著者：
このコンテンツについて
For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/KPN865. CME/MOC/NCPD/AAPA credit will be available until December 23, 2026.
Unpacking the Latest Evidence on Biomarkers and ATTs in the Diagnosis and Management of Alzheimer's Disease: Breaking Updates From CTAD 2025
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by an educational grant from Lilly.
Disclosure information is available at the beginning of the video presentation.